PL
BIIB icon

Polianta Ltd’s Biogen BIIB Stock Holding History

Polianta Ltd’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,800
Closed -$1.02M – 69
2020
Q2 		$1.02M Buy
+3,800
New +$1.14M 0.66% 32
2019
Q1 		– Sell
-3,530
Closed -$1.06M – 68
2018
Q4 		$1.06M Buy
+3,530
New +$1.13M 0.53% 54
2018
Q3 		– Sell
-4,000
Closed -$1.16M – 76
2018
Q2 		$1.16M Buy
+4,000
New +$1.12M 0.36% 42

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Polianta Ltd's BIIB Position: Q3 2020 in Review

Polianta Ltd sold out of Biogen (BIIB) in Q3 2020, closing a stake of 3,800 shares — an estimated $1.02M sold.

Polianta Ltd first reported a position in BIIB in Q2 2018 and held it in 3 quarters. The position peaked at $1.16M in Q2 2018. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Polianta Ltd reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Polianta Ltd sold 3,800 Biogen shares in Q3 2020, an estimated $1.02M.
  • Polianta Ltd first reported a position in Biogen in Q2 2018 and held it in 3 quarters.
  • Polianta Ltd's Biogen position peaked at $1.16M in Q2 2018.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Polianta Ltd's 13F filing for Q3 2020, filed 7 Oct 2020.